Aimmune Therapeutics to Present New Data for PALFORZIA® [Peanut (Arachis hypogaea) Allergen Powder-dnfp] at the EAACI Hybrid Congress 2022
— Analysis to be Presented Showed Peanut Allergy Treatment with PALFORZIA was Associated with Improvements in Health-Related Quality of Life among Patients and Caregivers— —Additional Data to be Presented Suggested Increased Satisfaction Rates Associated with Convenience and Effectiveness of PALFORZIA Treatment— BRISBANE, Calif.–(BUSINESS WIRE)–Aimmune Therapeutics, Inc., a Nestlé Health Science company developing pharmaceutical therapies to … [Read more…]
